Pediatric Nephrology

, Volume 26, Issue 12, pp 2099–2109

Sickle cell nephropathy: challenging the conventional wisdom


DOI: 10.1007/s00467-010-1736-2

Cite this article as:
Becker, A.M. Pediatr Nephrol (2011) 26: 2099. doi:10.1007/s00467-010-1736-2


This review explores the current model of sickle cell nephropathy and the limitations of the model. Renal abnormalities are common complications of sickle cell disease (SCD). Beginning in childhood, patients with SCD develop a urinary concentrating defect resulting in polyuria and a predisposition to nocturnal enuresis and dehydration. The current model of sickle cell nephropathy suggests that destruction of the renal medulla induces production of renal vasodilating substances that feedback to the glomerulus causing hyperfiltration. Hyperfiltration leads to glomerulosclerosis and proteinuria, with eventual reduction in kidney function. The crucial steps of vasodilating substance production and hyperfiltration in children with SCD have not been proven. Treatment of sickle cell nephropathy is aimed at the reduction of proteinuria with angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Hydroxyurea and chronic transfusion therapy may also alter the progression of sickle cell nephropathy in children. Further studies are needed to identify an accurate model and effective treatments for sickle cell nephropathy.


Sickle cell anemia Hyperfiltration Proteinuria Chronic kidney disease Prostaglandins 

Copyright information

© IPNA 2011

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations